Challenge

Alber & Geiger assisted a US Fortune 500 chemical company to tackle the issue of illegal trade of refrigerants. For years, illegal trade of old generation refrigerants in Europe, prevented and delayed the introduction of high-end, climate friendly solutions. In parallel, the ongoing revision of the EU F-Gas Regulation was not delivering the expected results on phasing down the use of HFCs, as stricter penalties and measures to control illegal trade could only be enforced on a Member State level.

Strategy

Our team therefore embarked on a legislative initiative in Germany, which would offer a national solution that would inspired other Member States to use the German law as a blueprint. Alber & Geiger enforced a strategy which appealed to all levels of the German political institutions and administration. We supported the proposal on the level of the federal government, while in parallel gathering support at various political levels. Moving forward successfully, we managed to get our arguments through to stakeholders also in the European Union.

Results

On a first stage, Alber & Geiger supported a draft legislation which was in favor of our client’s expectations. On a second stage, our team also saw through the clearance of the German legislation from the EU Commission and inspire other Member States follow the German path. Finally, we locked the support from the German upper house and rapporteurs of the lower house, succeeding in the eventual speedy adoption of the legislation, which will be hopefully used as a blueprint solution in the EU.

Challenge

The Ukrainian company Milkiland had been ignored and effectively passed down with respect to a crucial development loan from the European Bank for Reconstruction and Development (EBRD). Milkiland sought out help. The challenge was to overcome the network of interests that were blocking the EBRD from assessing the request of Milkiland on the face of it.

Strategy

The strategy was for us to simulate a check and balance mechanism in a more private context, within the nature of EBRD, being positioned in between the public and private domain. We co-ordinated the relevant playmakers and acquired a detailed awareness of EBRD’s internal politics. We delicately navigated the assortment of economic and political objectives and obligations.

We put forward that the behaviour of the EBRD was contrary to the purpose of the organization. By prejudicing the position of a Ukrainian company, it was acting against the stated objective of helping Ukraine become a stand-alone market economy.

Results

The result was a tremendous 30 million dollar loan for Milkiland. This achievement was the consequence of a careful triangulation of sensitive political and private interests. Legal and institutional certainty, and ethical business behaviour, are now a cause for enhanced development prospects in Ukraine.

Challenge

A US Fortune 500 chemical company approached Alber & Geiger seeking regulatory and advocacy support over a European Union proposal that would have classified Titanium Dioxide as a cat.2 suspected carcinogen by inhalation. Such a decision would have affected our client’s revenue and increased risk of similar regulatory measures in the other jurisdictions across the globe.

Strategy

With the experts opinion from the ECHA’s Risk Assessment Committee delivered to the European Commission, our team quickly embarked on a campaign aimed at highlighting the broader ramifications of classification on other EU policies and beyond Titanium Dioxide.

We pursued a strategy that put the spotlight on loss of consumer choice, impact on jobs and EU competitiveness as well as cost to downstream users. Alber & Geiger also broadened the issue to include political considerations and other players. On top of the European Commission, in particular DG Envi and DG Grow and the Member States’ Competent Authorities, we reached out to the Permanent Representations of the Member States as well as select Members of the European Parliament.

Results

Our advocacy helped thwart the original carcinogen classification that would have harmed our client. Through active engagement at the regulatory and political level, we helped find a suitable compromise for our client, which was then mirrored in the European Commission amended proposal.

Instead of outright carcinogen labelling on Titanium Dioxide, the European Commission changed its position by agreeing for classification to apply to Titanium Dioxide in powder form, only on the level of manufacture and without carcinogenicity labelling in the end products.